180 related articles for article (PubMed ID: 24706015)
1. Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS).
Wright CB; Dong C; Stark M; Silverberg S; Rundek T; Elkind MS; Sacco RL; Mendez A; Wolf M
Neurology; 2014 May; 82(19):1700-6. PubMed ID: 24706015
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.
Shah NH; Dong C; Elkind MS; Sacco RL; Mendez AJ; Hudson BI; Silverberg S; Wolf M; Rundek T; Wright CB
Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2048-53. PubMed ID: 26112008
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
Wright CB; Shah NH; Mendez AJ; DeRosa JT; Yoshita M; Elkind MS; Sacco RL; DeCarli C; Rundek T; Silverberg S; Dong C; Wolf M
Stroke; 2016 Apr; 47(4):923-8. PubMed ID: 26956260
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 and risk of incident stroke in community-living adults.
Panwar B; Jenny NS; Howard VJ; Wadley VG; Muntner P; Kissela BM; Judd SE; Gutiérrez OM
Stroke; 2015 Feb; 46(2):322-8. PubMed ID: 25563643
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study.
Souma N; Isakova T; Lipiszko D; Sacco RL; Elkind MS; DeRosa JT; Silverberg SJ; Mendez AJ; Dong C; Wright CB; Wolf M
J Clin Endocrinol Metab; 2016 Oct; 101(10):3779-3786. PubMed ID: 27501282
[TBL] [Abstract][Full Text] [Related]
6. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
[TBL] [Abstract][Full Text] [Related]
7. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
Isakova T; Wahl P; Vargas GS; Gutiérrez OM; Scialla J; Xie H; Appleby D; Nessel L; Bellovich K; Chen J; Hamm L; Gadegbeku C; Horwitz E; Townsend RR; Anderson CA; Lash JP; Hsu CY; Leonard MB; Wolf M
Kidney Int; 2011 Jun; 79(12):1370-8. PubMed ID: 21389978
[TBL] [Abstract][Full Text] [Related]
9. Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals.
Isakova T; Cai X; Lee J; Katz R; Cauley JA; Fried LF; Hoofnagle AN; Satterfield S; Harris TB; Shlipak MG; Sarnak MJ; Ix JH;
J Bone Miner Res; 2016 Apr; 31(4):742-8. PubMed ID: 26590361
[TBL] [Abstract][Full Text] [Related]
10. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.
Nakano C; Hamano T; Fujii N; Matsui I; Tomida K; Mikami S; Inoue K; Obi Y; Okada N; Tsubakihara Y; Isaka Y; Rakugi H
Clin J Am Soc Nephrol; 2012 May; 7(5):810-9. PubMed ID: 22362065
[TBL] [Abstract][Full Text] [Related]
11. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
[TBL] [Abstract][Full Text] [Related]
12. Residential Proximity to Major Roadways and Risk of Incident Ischemic Stroke in NOMAS (The Northern Manhattan Study).
Kulick ER; Wellenius GA; Boehme AK; Sacco RL; Elkind MS
Stroke; 2018 Apr; 49(4):835-841. PubMed ID: 29540609
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients.
Sugimoto H; Ogawa T; Iwabuchi Y; Otsuka K; Nitta K
Int Urol Nephrol; 2014 Jan; 46(1):99-106. PubMed ID: 23355029
[TBL] [Abstract][Full Text] [Related]
14. Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology.
Ärnlöv J; Carlsson AC; Sundström J; Ingelsson E; Larsson A; Lind L; Larsson TE
Clin J Am Soc Nephrol; 2013 May; 8(5):781-6. PubMed ID: 23335040
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs).
Westerberg PA; Tivesten Å; Karlsson MK; Mellström D; Orwoll E; Ohlsson C; Larsson TE; Linde T; Ljunggren Ö
BMC Nephrol; 2013 Apr; 14():85. PubMed ID: 23587028
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
[TBL] [Abstract][Full Text] [Related]
20. Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study.
Fyfe-Johnson AL; Alonso A; Selvin E; Bower JK; Pankow JS; Agarwal SK; Lutsey PL
J Hypertens; 2016 Jul; 34(7):1266-72. PubMed ID: 27100793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
